Next-Generation Whole-Body MRI for Detection and Assessment of Therapy Response in Bone Lesions
用于检测和评估骨病变治疗反应的新一代全身 MRI
基本信息
- 批准号:10716642
- 负责人:
- 金额:$ 54.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AbdomenAddressAnatomyBone MarrowBone Marrow TransplantationBone marrow biopsyChestClinicalClinical TrialsDetectionDevelopmentDiagnosisDiagnosticDiffusionDiffusion Magnetic Resonance ImagingDiseaseFatty acid glycerol estersGenerationsGoalsImageImage EnhancementImaging TechniquesImaging technologyIndustry StandardLesionLimb structureLiquid substanceLocalized LesionLocationMagnetic Resonance ImagingMalignant NeoplasmsMalignant neoplasm of prostateMapsMarrowMeasurementMeasuresMetastatic Neoplasm to the BoneMethodsMorphologic artifactsMotionMultiple MyelomaMusculoskeletalNeoadjuvant TherapyNon-MalignantOutcomePET/CT scanPainParalysedPathological fracturePathologyPatient CarePatientsPelvisPerformancePerfusionPrognosisPrognostic MarkerProgression-Free SurvivalsProtocols documentationQuality of lifeRecommendationReference StandardsRenal carcinomaResolutionRoentgen RaysScanningSignal TransductionSkeletonSolid NeoplasmTestingTimeVertebral columnVisualizationbonebone imagingbone lossclinical practiceclinical translationclinically relevantcontrast enhancedcostcost effectiveexperiencefluorodeoxyglucose positron emission tomographyimaging biomarkerimaging detectionimaging modalityimprovedin vivoinnovationmalignant breast neoplasmneoplastic cellnext generationnovelpediatric patientsspinal cord compressionstandard of caretreatment responsetumor
项目摘要
Project Summary
Bone lesions from solid tumors such as breast, prostate, or kidney cancers, tumors originating in the bone
marrow such as multiple myeloma (MM), or other non-malignant musculoskeletal pathologies can occur
anywhere in the skeleton. These bone lesions cause pain and spinal cord compressions, leading to pathologic
fractures and paralysis, thereby diminishing the patient's quality of life. Current therapies rely on diagnosing
these bone lesions by whole-body X-ray or bone scans, which only identify them at advanced stages. While
whole-body magnetic resonance imaging (WBMRI) is recommended for pretreatment assessment (e.g., in
MM), MRI is often limited to spine and pelvic regions in practice to minimize patient discomfort, compromised
image quality from geometric distortion, and high costs due to prolonged acquisition times. To address this
unmet clinical need, we developed a novel WBMRI technique: `Dual-Echo T2-weighted acquisition for
Enhanced Conspicuity of Tumors' (DETECT), for improved lesion visualization by simultaneously separating
the confounding signals of fat and fluid. Compared to WBMRI with diffusion-weighted imaging (DWI), single-
shot DETECT increased lesion detection (>40%) in considerably shorter scan times (<10 min) and without
image distortions. This method also improved robustness to motion in the thoracic and abdomen regions,
however, it suffers from image blurring due to T2-decay particularly in spine and extremities, limiting the
diagnostic performance. In the current proposal, we will address these limitations by developing the next-
generation WBMRI-DETECT using an efficient combination of single-shot and multi-shot acquisitions. DETECT
also generates fat signal for quantitative fat fraction (FF) maps that can be used as a prognostic biomarker in
MM, since tumor cells replace fat, a major constituent of bone marrow. This method also led us to develop a
DETECT-based DWI technique for accurate measurement of apparent diffusion coefficient (ADC). The specific
aims are: 1) To develop an integrated WBMRI using single-shot and multi-shot DETECT, along with
quantitative FF maps; 2) To develop a DETECT-based DWI with accurate ADC measurements; and 3) To
evaluate the integrated WBMRI, including DETECT-DWI and contrast-enhanced perfusion, for efficient bone
lesion detection and therapy response assessment. We will use bone lesions in MM as the proof-of-concept
disease to achieve these project goals. The successful outcome of this project will be an efficient WBMRI
protocol with accurate FF and ADC measures as imaging biomarkers, validated in detection and measuring
therapy response in MM patients. This WBMRI in combination with contrast-enhanced MRI including perfusion,
will be an excellent cost-effective and practical approach (<45 minutes of table time) for widespread use in
clinical practices across the world. This will benefit MM patients and patients suffering from other bone lesions,
including pediatric patients during long follow-ups, without the drawbacks of PET/CT. This will provide relevant
clinical information for treatment decisions to positively impact patients' quality of life and overall survival.
项目摘要
来自实体瘤的骨病变,如乳腺癌、前列腺癌或肾癌,肿瘤起源于骨
可能发生骨髓炎,如多发性骨髓瘤(MM)或其他非恶性肌肉骨骼病变
在骨架的任何地方。这些骨病变引起疼痛和脊髓压迫,导致病理性
骨折和瘫痪,从而降低患者的生活质量。目前的治疗方法依赖于诊断
这些骨病变通过全身X光或骨扫描,这只会发现他们在先进的阶段。而
推荐全身磁共振成像(WBMRI)用于治疗前评估(例如,在
MM),MRI在实践中通常仅限于脊柱和骨盆区域,以最大限度地减少患者不适,
几何失真造成的图像质量问题,以及由于采集时间延长造成的高成本问题。为了解决这个
为了满足临床需求,我们开发了一种新的WBMRI技术:“双回波T2加权采集,
增强型肿瘤清晰度(DETECT),通过同时分离
脂肪和液体的混杂信号与WBMRI和弥散加权成像(DWI)相比,单次-
shot DETECT在相当短的扫描时间(<10分钟)内提高了病变检测率(>40%),并且没有
图像失真该方法还提高了对胸部和腹部区域中的运动的鲁棒性,
然而,由于特别是在脊柱和四肢中的T2衰减,其遭受图像模糊,限制了
诊断性能。在目前的提案中,我们将通过开发下一个解决这些限制-
使用单激发和多激发采集的有效组合生成WBMRI-DETECT。检测
还生成定量脂肪分数(FF)图的脂肪信号,可用作预后生物标志物,
MM,因为肿瘤细胞取代了骨髓的主要成分脂肪。这种方法也使我们开发了一种
基于DETECT的DWI技术,用于精确测量表观扩散系数(ADC)。具体
目的是:1)开发一个集成的WBMRI使用单次激发和多次激发检测,沿着
定量FF图; 2)开发具有准确ADC测量值的基于DETECT的DWI;以及3)
评价集成WBMRI,包括DETECT-DWI和对比增强灌注,以获得有效骨
病变检测和治疗反应评估。我们将使用多发性骨髓瘤的骨病变作为概念验证
为实现这些目标,该项目的成功结果将是一个有效的WBMRI
使用准确的FF和ADC测量作为成像生物标志物的方案,在检测和测量中得到验证
MM患者的治疗反应。该WBMRI与对比增强MRI(包括灌注)相结合,
将是一种非常具有成本效益和实用的方法(<45分钟的餐桌时间),可广泛用于
世界各地的临床实践。这将使MM患者和患有其他骨病变的患者受益,
包括长期随访期间的儿科患者,而没有PET/CT的缺点。这将提供相关
为治疗决策提供临床信息,以积极影响患者的生活质量和总生存期。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ananth Jayaseelan Madhuranthakam其他文献
Ananth Jayaseelan Madhuranthakam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ananth Jayaseelan Madhuranthakam', 18)}}的其他基金
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response
使用动脉旋转标记进行定量非对比灌注评估癌症治疗反应
- 批准号:
10475022 - 财政年份:2017
- 资助金额:
$ 54.82万 - 项目类别:
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response
使用动脉旋转标记进行定量非对比灌注评估癌症治疗反应
- 批准号:
9765190 - 财政年份:2017
- 资助金额:
$ 54.82万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 54.82万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 54.82万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 54.82万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 54.82万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 54.82万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 54.82万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 54.82万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 54.82万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 54.82万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 54.82万 - 项目类别:
Research Grant